Company: HCTI
Filing Date: 2025-05-09
Form Type: S-1/A
Source: 0001213900-25-041190
Chunk: 22

Company: Healthcare Triangle, Inc.
Filing Date: 2025-05-09
Form: S-1/A
Chunk 22
---
 to regain compliance with the Stockholders’ Equity Rule and to increase its working capital.

Terms of Private Placement

On February 27, 2025,
we entered into Securities Purchase Agreements with the selling stockholders for the private placement (the “Private Placement”)
of 36,190,485 Units, each Unit consisting of (i) one share of Common Stock; (ii) a Pre-Funded Warrant to purchase one share of common
stock; a Series A Warrant to purchase one share of common stock and one Series B Warrant to purchase one share of common stock at an
offering price of $0.42 per Unit (or $0.41999 per Unit in the case of Units that include pre-funded warrants). The Common Stock, the
Pre-Funded Warrants and the Purchase Warrants included in the Units and the Common Stock underlying the Pre-Funded Warrants and the Purchase
Warrants are collectively referred to herein as the “Securities” and the Securities, other than the Pre-Funded Warrants,
and the Purchase Warrants shall be referred to herein as the “Registrable Securities.” The entire transaction was priced
at the market under Nasdaq rules and closed on February 28, 2025.

The initial exercise price
for both the Series A Warrants and Series B Warrants is $0.84 per share and both the Series A Warrants and Series B Warrants terminate
on the fifth anniversary of the earlier of (i) the effective date of the registration statement related to this prospectus (the “Registration
Statement”) or (ii) the date that the Registerable Securities can be sold, assigned or transferred without restriction or limitation
pursuant to Rule 144 promulgated under the 1933 Act, as amended. The Purchase Warrants became exercisable on March 23, 2025, the effective
date of the approval by the stockholders of the exercise of the Purchase Warrants.

The Purchase Warrants
contain a one-time reset of the exercise price (subject to a floor of $0.084 per share) to a price equal to the lowest Weighted Average
Price (as defined in the Purchase Warrants) for the Common Stock during the period (the “Adjustment Period”) beginning two
(2) trading days immediately prior to the effective date of the Registration Statement and ending on the tenth (10) trading
day after the effective date of the Registration Statement (the “Adjustment Period End Date”). A reset of